Literature DB >> 22740866

A microRNA expression signature characterizing the properties of tumor-initiating cells for breast cancer.

Lixin Wang1, Daoqiang Zhang, Changwen Zhang, Shuping Zhang, Zhe Wang, Chen Qu, Sijin Liu.   

Abstract

microRNAs (miRNAs) are involved in controlling tumor behaviors either as oncogenes or tumor suppressors. To elucidate the role of miRNAs in the regulation of tumor initiation, we delineated the microRNA expression signature characterizing the properties of tumor-initiating cells for breast cancer. A group of miRNAs were differentially expressed in MDA-MB-231 and SUM1315 cells (with a high proportion of breast cancer tumor-initiating cells, CD44(+)CD24(-/low) subpopulation) compared to MCF-7 cells (only a small proportion of CD44(+)CD24(-/low) cells). Among the differentially expressed miRNAs common to MDA-MB-231 and SUM1315, approximately 46% of them are suggested to regulate the 'stemness' of stem cells or progenitor cells. Taken together, these findings suggested that miRNAs contribute to the maintenance of tumor-initiating properties and indicate the potential value of the miRNA expression signature in characterizing or predicting the features (including metastasis) of breast cancer.

Entities:  

Year:  2011        PMID: 22740866      PMCID: PMC3362495          DOI: 10.3892/ol.2011.431

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  48 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  MicroRNAs couple cell fate and developmental timing in retina.

Authors:  Sarah Decembrini; Dario Bressan; Robert Vignali; Letizia Pitto; Sara Mariotti; Giuseppe Rainaldi; Xiumei Wang; Monica Evangelista; Giuseppina Barsacchi; Federico Cremisi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

4.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.

Authors:  Yoon-Chi Han; Christopher Y Park; Govind Bhagat; Jinping Zhang; Yulei Wang; Jian-Bing Fan; Mofang Liu; Yongrui Zou; Irving L Weissman; Hua Gu
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

5.  Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Authors:  Sijin Liu; Robert H Goldstein; Ellen M Scepansky; Michael Rosenblatt
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

6.  Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.

Authors:  John Peter McPherson; Laura Tamblyn; Andrew Elia; Eva Migon; Amro Shehabeldin; Elzbieta Matysiak-Zablocki; Bénédicte Lemmers; Leonardo Salmena; Anne Hakem; Jason Fish; Farah Kassam; Jeremy Squire; Benoit G Bruneau; M Prakash Hande; Razqallah Hakem
Journal:  EMBO J       Date:  2004-09-02       Impact factor: 11.598

7.  REST maintains self-renewal and pluripotency of embryonic stem cells.

Authors:  Sanjay K Singh; Mohamedi N Kagalwala; Jan Parker-Thornburg; Henry Adams; Sadhan Majumder
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

8.  A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment.

Authors:  Agnieszka Rybak; Heiko Fuchs; Lena Smirnova; Christine Brandt; Elena E Pohl; Robert Nitsch; F Gregory Wulczyn
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

9.  MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells.

Authors:  Srikumar Sengupta; Jeff Nie; Ryan J Wagner; Chuhu Yang; Ron Stewart; James A Thomson
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

10.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

View more
  6 in total

Review 1.  Role of microRNAs in breast cancer.

Authors:  Ramesh Singh; Yin-Yuan Mo
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

2.  MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.

Authors:  Radha Munagala; Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

3.  A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.

Authors:  Alakesh Bera; Kolaparthi VenkataSubbaRao; Muthu Saravanan Manoharan; Ping Hill; James W Freeman
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 4.  An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance.

Authors:  Alessia Carta; Rachel Chetcuti; Duncan Ayers
Journal:  Genet Res Int       Date:  2014-12-04

5.  Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.

Authors:  Omer Faruk Karatas; Ilknur Suer; Betul Yuceturk; Mehmet Yilmaz; Buge Oz; Gulgun Guven; Harun Cansiz; Chad J Creighton; Michael Ittmann; Mustafa Ozen
Journal:  BMC Cancer       Date:  2016-11-05       Impact factor: 4.430

6.  OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition.

Authors:  Hunter Covert; Liliana F Mellor; Cody L Wolf; Nicole Ankenbrandt; Jacqueline M Emathinger; Ken Tawara; Julie Thom Oxford; Cheryl L Jorcyk
Journal:  Cancer Manag Res       Date:  2019-08-15       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.